Trailing Dividend / Share
$0.00
Mineralys Therapeutics, Inc. (MLYS) Dividend History
Income profile from 2020 to 2024 with payout safety and yield-on-cost trend
Dividend Yield
N/A
Payout Ratio
N/A
Unknown
Dividend Streak
0 years
3-Second Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
Dividend Scorecard
Yield & Income
Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0
Payout Safety
Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score1/9
Growth
Growth Streak0 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown
Total Returns
Buyback Yield0.0%
Total Shareholder Yield0.0%
1Y Total Return220.1%
5Y Total Return58.7%
Estimated $10K growth (return + dividends):
5Y ago$15,86810Y ago$15,86820Y ago$15,868
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
Dividend History
No dividend payment history available
This company has not paid dividends during the available data period.
Dividend Analysis
Payout Safety
Mineralys Therapeutics, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 1/9 — weak financial health.
Growth Track Record
MLYS does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, MLYS returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is 58.7%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $15,868 today.
Dividend Peer Comparison
Peer group: Commercial Specialty Pharma
Div Yield
—
—
Safety
Unknown
— payout
Streak
0Y
— 5Y CAGR
Total Shareholder
0.0%
#4 of 4
Annual Dividend History
5 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | — | 0 | $-3.66 | — | — | — |
| 2023 | $0.00 | — | 0 | $-1.99 | — | — | — |
| 2022 | $0.00 | — | 0 | $-5.77 | — | — | — |
| 2021 | $0.00 | — | 0 | $-3.89 | — | — | — |
| 2020 | $0.00 | — | 0 | $-0.74 | — | — | — |
See MLYS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MLYS Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare MLYS vs AGIO
See how MLYS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How much dividend does MLYS pay per share?
Mineralys Therapeutics, Inc. (MLYS) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is MLYS's next ex-dividend date?
MLYS's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. MLYS typically pays dividends quarterly.
Is MLYS's dividend safe?
MLYS's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has MLYS increased its dividend?
MLYS has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does MLYS pay dividends?
Mineralys Therapeutics, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 4+ years from 2020 to 2024.
How much would $10,000 invested in MLYS grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in MLYS five years ago would be worth approximately $15,868 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is MLYS's yield on cost for long-term holders?
MLYS's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.